ReviewAnnals of translational medicine2026
Ferritin as a diagnostic point-of-care marker in iron deficiency anemia: a narrative review and clinical implications.
Review in Annals of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background and Objective: Iron deficiency anemia (IDA) is the most common cause of anemia in pregnancy and is associated with significant maternal and perinatal morbidities, warranting early identification and aggressive management. Point-of-care (POC) devices that measure serum ferritin may offer a faster and more accessible alternative to traditional hemoglobin or laboratory testing for evaluating iron status. However, there is little information available on the use of ferritin POC devices to diagnose IDA, particularly in pregnancy. In this review, we outline the role of ferritin in IDA and provide a comprehensive analysis of contemporary ferritin measurement methods, including POC testing, to enhance the early identification and management of IDA. Methods: A review of peer-reviewed literature published in English from database inception to June 2026 and retrieved from PubMed and Google Scholar was conducted using keywords such as ferritin; iron deficiency anemia (IDA); screening; diagnosis; management; point-of-care (POC); and iron status. Key Content and Findings: Ferritin is a significant diagnostic marker for IDA. Utilizing ferritin levels for IDA diagnosis has several benefits and limitations, particularly in groups experiencing simultaneous inflammatory conditions. Advancements in POC ferritin testing devices offer potential to enhance the screening and management of IDA, especially in resource-limited environments. Conclusions: POC ferritin testing presents a valuable opportunity to improve the efficiency and accessibility of IDA diagnostics, paving the way for improved anemia management and patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.